Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PHiD-CV versus PCV-13 booster at 12 months after infant PCV-13 priming
2011-005102-30Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Nov 2011
- Modality
- Vaccines & Immunotherapeutics, Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of 10-valent pneumococcal conjugate vaccine, pneumococcal 13-valent conjugate vaccine in pneumococcal disease, sponsored by University of Oxford. Started Nov 2011; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccinepneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2011-005102-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005102-30.